News Bastide Le Confort Médical London S.E.

Equities

0IP1

FR0000035370

Market Closed - London S.E. Other stock markets 11:30:39 2024-04-16 am EDT			5-day change	1st Jan Change
15.62 ^EUR	-54.92%		-21.19%	-41.49%

May. 15	BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction
May. 15	Bastide: 8.2% increase in quarterly sales	CF

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction	May. 15
Bastide: 8.2% increase in quarterly sales	May. 15	CF
Bastide Le Confort Médical : Organic growth accelerated in third quarter 2023-2024 up 7.5% and sale of Homecare business in Switzerland in progress	May. 15	AT
2024.05.15 Organic growth accelerated in third quarter 2023 2024: up 7.5% Sale of Homecare business in Switzerland in progress 2023 2024 targets adjusted from scope effect confirmed	May. 15	PU
BASTIDE LE CONFORT MEDICAL : EPS upgrade (2023: 0.0%, 2024: +1.6%)	Apr. 09
Bastide: new contract with the British NHS	Apr. 09	CF
Bastide Le Confort Médical : Respiratory care therapy: Bastide wins new United Kingdom region - EUR 10 million/year contract for a minimum of seven years	Apr. 08	AT
BASTIDE LE CONFORT MEDICAL : The prioritised debt reduction awaits further visible progress	Mar. 21
Bastide Le Confort Médical : 2023-2024 half-yearly results : Organic growth up 5.7%, EBITDA up 7.5%, Increase in recurring operating profit despite the inflationary context and margin of 8.3%. 2023-2024 outlook confirmed	Mar. 20	AT
Bastide Le Confort Médical SA Reports Earnings Results for the Half Year Ended December 31, 2023	Mar. 20	CI
BASTIDE LE CONFORT MEDICAL : Reiterated guidance and further progress on the in debt profile	Feb. 15
Bastide: half-year sales up 5.7% organically	Feb. 15	CF
Bastide Le Confort Médical : Organic growth accelerated to 6.1% in second-quarter 2023-2024 and confirmation of 2023-2024 adjusted targets	Feb. 15	AT
Bastide Le Confort Offloads Majority Owned Medical Devices Seller Distrimed	Dec. 05	MT
Bastide: sells its Distrimed subsidiary to the Hygie31 group	Dec. 04	CF
Bastide Le Confort Médical : Strategic sale of e-commerce subsidiary Distrimed	Dec. 04	AT
Hygie31 acquired 70% stake in Distrimed SAS from Bastide Le Confort Médical SA.	Dec. 03	CI
BASTIDE LE CONFORT MEDICAL : Reconfirmed outlook and early progress in debt profile improvement	Nov. 19
Bastide: 7% sales growth in Q1	Nov. 17	CF
Bastide Le Confort Médical : Dynamic 7% growth in first-quarter 2023-2024 / 2023-2024 targets confirmed	Nov. 16	AT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction

May 15, 2024 at 02:40 pm EDT